These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38653657)

  • 1. [Not Available].
    Bajeot AS; Roumiguié M
    Ann Pathol; 2024 May; 44(3):183-187. PubMed ID: 38653657
    [No Abstract]   [Full Text] [Related]  

  • 2. Urine cytology of transitional cell neoplasms.
    Rife CC; Farrow GM; Utz DC
    Urol Clin North Am; 1979 Oct; 6(3):599-612. PubMed ID: 505675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
    Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
    Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urinary cytology of transitional-cell carcinoma].
    Piazza G; Galia A; Cosentino A; Grasso G
    Pathologica; 1995 Apr; 87(2):146-7. PubMed ID: 8532407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary cytology for the detection of urothelial lesions].
    Duchêne L; Davenne É; Lifrange F; Detrembleur N; Delporte G; Waltregny D; Delvenne P
    Rev Med Liege; 2024 Jun; 79(5-6):424-428. PubMed ID: 38869134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Tract Cytopathology: Current and Future Impact on Patient Care.
    Jorda M; Kryvenko ON; Hanly F; Zuo Y
    Surg Pathol Clin; 2024 Sep; 17(3):383-394. PubMed ID: 39129138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What contribution can make artificial intelligence to urinary cytology?].
    Lacoste-Collin L
    Ann Pathol; 2024 May; 44(3):195-203. PubMed ID: 38614871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathology of Urothelial Carcinoma.
    Al-Ahmadie H; Netto GJ
    Clin Lab Med; 2024 Jun; 44(2):181-198. PubMed ID: 38821640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.
    Sanguedolce F; Russo D; Calò B; Cindolo L; Carrieri G; Cormio L
    Pathol Res Pract; 2019 Jun; 215(6):152413. PubMed ID: 30987832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine cytology in patients with calculi.
    Highman W; Wilson E
    J Clin Pathol; 1982 Mar; 35(3):350-6. PubMed ID: 7068927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Paris System in atypical urinary cytology.
    Mikou P; Lenos M; Papaioannou D; Vrettou K; Trigka EA; Sousouris S; Constantinides C
    Cytopathology; 2018 Dec; 29(6):545-549. PubMed ID: 30066427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cytopathological factors affecting the cellularity of urinary cell blocks and the implication for diagnosis and follow-up of urinary bladder urothelial carcinoma.
    Brisuda A; Háček J; Čechová M; Škapa P; Babjuk M
    Cytopathology; 2018 Dec; 29(6):537-544. PubMed ID: 29873845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. We'll always have Paris The Paris System for Reporting Urinary Cytology 2022.
    Wojcik EM; Kurtycz DFI; Rosenthal DL
    J Am Soc Cytopathol; 2022; 11(2):62-66. PubMed ID: 35094954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].
    Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
    Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
    Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytodiagnosis of non-papillary carcinoma of the bladder and its clinico-pathological significance].
    Yamada T; Shibasaki M; Takagi M; Yokogawa M; Inada T; Fukui I
    Rinsho Byori; 1980; Suppl():188-99. PubMed ID: 7411958
    [No Abstract]   [Full Text] [Related]  

  • 18. The diagnostic value of urinary cytology in patients with bladder carcinoma.
    Schoonees R; Gamarra MG; Moore RH; Murphy GP
    J Urol; 1971 Nov; 106(5):693-6. PubMed ID: 5115726
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
    Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
    Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reliability of urinary cytology for follow-up of bladder cancer].
    Ginesin Y; Malberger E; Semberg S; Levin DR
    Harefuah; 1987 Sep; 113(5-6):101-3. PubMed ID: 3692366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.